Showing 1 - 12 results of 12 for search 'Ulrika S. H. Simonsson', query time: 0.06s Refine Results
  1. 1
    Individualized Dosing With High Inter-Occasion Variability Is Correctly Handled With Model-Informed Precision Dosing-Using Rifampicin as an Example

    Individualized Dosing With High Inter-Occasion Variability Is Correctly Handled With Model-Informed Precision Dosing-Using Rifampicin as an Example by Lina Keutzer, Ulrika S. H. Simonsson

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Finding the right hazard function for time‐to‐event modeling: A tutorial and Shiny application

    Finding the right hazard function for time‐to‐event modeling: A tutorial and Shiny application by Rob C. VanWijk, Ulrika S. H. Simonsson

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    A modeling‐based proposal for safe and efficacious reintroduction of bedaquiline after dose interruption: A population pharmacokinetics study

    A modeling‐based proposal for safe and efficacious reintroduction of bedaquiline after dose interruption: A population pharmacokinetics study by Lina Keutzer, Yasamin Akhondipour Salehabad, Lina Davies Forsman, Ulrika S. H. Simonsson

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Phase III dose selection of marzeptacog alfa (activated) informed by population pharmacokinetic modeling: A novel hemostatic drug

    Phase III dose selection of marzeptacog alfa (activated) informed by population pharmacokinetic modeling: A novel hemostatic drug by Alan Faraj, Tom Knudsen, Shraddha Desai, Linda Neuman, Grant E. Blouse, Ulrika S. H. Simonsson

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment

    Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment by Lina Keutzer, Laurynas Mockeliunas, Marieke G. G. Sturkenboom, Mathieu S. Bolhuis, Onno W. Akkerman, Ulrika S. H. Simonsson

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Seasonal influence on respiratory tract infection severity including COVID‐19 quantified through Markov Chain modeling

    Seasonal influence on respiratory tract infection severity including COVID‐19 quantified through Markov Chain modeling by Rob C. vanWijk, Laurynas Mockeliunas, Caryn M. Upton, Jonathan Peter, Andreas H. Diacon, Ulrika S. H. Simonsson

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Model‐informed pediatric dose selection of marzeptacog alfa (activated): An exposure matching strategy

    Model‐informed pediatric dose selection of marzeptacog alfa (activated): An exposure matching strategy by Alan Faraj, Rob C. vanWijk, Linda Neuman, Shraddha Desai, Grant E. Blouse, Tom Knudsen, Ulrika S. H. Simonsson

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis

    Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis by Laurynas Mockeliunas, Lina Keutzer, Marieke G. G. Sturkenboom, Mathieu S. Bolhuis, Lotte M. G. Hulskotte, Onno W. Akkerman, Ulrika S. H. Simonsson

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  9. 9
    Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development

    Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development by Laurynas Mockeliunas, Alan Faraj, Rob C. van Wijk, Caryn M. Upton, Gerben van den Hoogen, Andreas H. Diacon, Ulrika S. H. Simonsson

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  10. 10
    Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs: An evaluation of in vitro, in vivo methodologies and human studies

    Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs: An evaluation of in vitro, in vivo methodologies and human studies by Jan-Willem C. Alffenaar, Jan-Willem C. Alffenaar, Jan-Willem C. Alffenaar, Jurriaan E. M. de Steenwinkel, Andreas H. Diacon, Ulrika S. H. Simonsson, Shashikant Srivastava, Sebastian G. Wicha

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  11. 11
    Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug development

    Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug development by Rami Ayoun Alsoud, Robin J. Svensson, Elin M. Svensson, Elin M. Svensson, Stephen H. Gillespie, Martin J. Boeree, Andreas H. Diacon, Rodney Dawson, Rodney Dawson, Rob E. Aarnoutse, Ulrika S. H. Simonsson

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  12. 12
    Machine Learning and Pharmacometrics for Prediction of Pharmacokinetic Data: Differences, Similarities and Challenges Illustrated with Rifampicin

    Machine Learning and Pharmacometrics for Prediction of Pharmacokinetic Data: Differences, Similarities and Challenges Illustrated with Rifampicin by Lina Keutzer, Huifang You, Ali Farnoud, Joakim Nyberg, Sebastian G. Wicha, Gareth Maher-Edwards, Georgios Vlasakakis, Gita Khalili Moghaddam, Elin M. Svensson, Michael P. Menden, Ulrika S. H. Simonsson, on behalf of the UNITE4TB Consortium

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: